| Interleukin-18 binding protein deficiency results in gut microbiota dysbiosis and aggravated diet-induced MASH in mice | JHEP reports | | | 2026 | 52 | 71 |
|
| Diabétologie : ce qui a changé en 2025 | Revue médicale suisse | | | 2026 | 30 | 0 |
|
| Autoimmunity in MASLD : Focus on autoantibodies, anti‐apolipoprotein A1 IgG and G protein‐coupled receptors | European journal of clinical investigation | | | 2025 | 91 | 431 |
|
| Prise en charge de la dyslipidémie diabétique | Revue médicale suisse | | | 2025 | 18 | 0 |
|
| Autoantibodies against apolipoprotein A-1 and cadmium : possible links tocardiovascular and liver diseases across multiple models | ESC (European Society of Cardiology) Congress 2025 | | | 2025 | 22 | 0 |
|
| Autoantibodies against apolipoprotein A-1 and cadmium : Possible links tocardiovascular and liver diseases across multiple models | 93rd EAS (European Atherosclerosis Society) Congress | | | 2025 | 28 | 0 |
|
| Modulation of STAT6 signaling for hepatoprotection | Frontiers in pharmacology | | | 2025 | 18 | 146 |
|
| Interleukin-18 binding protein protects against metabolic steatohepatitis | Hepatology communications | | | 2025 | 10 | 29 |
|
| Analogues du GLP-1 dans le traitement du diabète de type 2 et de l’obésité : la panacée ? | Revue médicale suisse | | | 2025 | 21 | 0 |
|
| Multi-omics correlates of insulin resistance and circadian parameters mapped directly from human serum | European journal of neuroscience | | | 2024 | 97 | 285 |
|
| Alterations of lipid homeostasis in morbid obese patients are partly reversed by bariatric surgery | iScience | | | 2024 | 102 | 114 |
|
| S100A9 exerts insulin-independent antidiabetic and anti-inflammatory effects | Science advances | | | 2024 | 360 | 220 |
|
| Linking antibody against apolipoprotein A-1 to nonalcoholic steatohepatitis in mice | 92nd EAS (European Atherosclerosis Society) Congress | | | 2024 | 18 | 0 |
|
| Corticosteroid therapy in older adults with cancer : Expert recommendations from a task force of the International Society of Geriatric Oncology | Journal of geriatric oncology | | | 2024 | 47 | 0 |
|
| Linking antibody against apolipoprotein A-1 to metabolic dysfunction-associatedsteatohepatitis in mice | ESC (Europan Society of Cardiology) Congress 2024 | | | 2024 | 16 | 0 |
|
| Geospatial clustering of auto-antibodies against apolipoprotein A-1, heavy metals,cardiovascular and liver diseases in the general population | ESC (Europan Society of Cardiology) Congress 2024 | | | 2024 | 20 | 0 |
|
| Diabétologie : ce qui a changé en 2023 | Revue médicale suisse | | | 2024 | 127 | 28 |
|
| Lysophosphatidylinositols Are Upregulated After Human β-Cell Loss and Potentiate Insulin Release | Diabetes | | | 2024 | 379 | 3 |
|
| N ADPH oxidases in healthy white adipose tissue and in obesity : function, regulation, and clinical implications | Obesity | | | 2024 | 120 | 128 |
|
| Linking Antibodies Against Apolipoprotein A-1 to Metabolic Dysfunction-Associated Steatohepatitis in Mice | International journal of molecular sciences | | | 2024 | 137 | 189 |
|
| Gastroparésie diabétique et diabète de type 1 | Revue médicale suisse | | | 2024 | 148 | 20 |
|
| Langerhans Cell Histiocytosis of the Suprasellar Region : Diagnosis on Thyroid Cytology | European thyroid journal | | | 2024 | 131 | 272 |
|
| Geospatial clustering of auto-antibodies against apolipoprotein A-1, heavy metals, cardiovascular and liver diseases in the general population | 92nd EAS (European Atherosclerosis Society) Congress | | | 2024 | 21 | 0 |
|
| Gynécologie-obstétrique. Prise en charge et dépistage du diabète gestationnel : ce qui a changé en 2023 | Revue médicale suisse | | | 2024 | 238 | 15 |
|
| Toutes nos différences… | Revue médicale suisse | | | 2024 | 97 | 13 |
|
| Interprofessional diabetes and foot management in low-and middle-income countries or humanitarian crises contexts | International Diabetes Federation (IDF) virtual congress | | | 2023 | 68 | 116 |
|
| Pied diabétique : une prise en charge complexe et multidisciplinaire | Revue médicale suisse | | | 2023 | 140 | 60 |
|
| Nonalcoholic fatty liver disease in type 1 diabetes : where are we? | Polskie Archiwum Medycyny Wewnętrznej | | | 2023 | 102 | 122 |
|
| GLP-1 receptor agonists effect on cognitive function in patients with and without type 2 diabetes | Diabetes & metabolism | | | 2023 | 145 | 706 |
|
| A global research priority agenda to advance public health responses to fatty liver disease | Journal of hepatology | | | 2023 | 129 | 705 |
|
| Diabétologie : ce qui a changé en 2022 | Revue médicale suisse | | | 2023 | 159 | 48 |
|
| Role of Oxidative Stress and Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 in Nonalcoholic Fatty Liver Disease | International journal of molecular sciences | | | 2023 | 143 | 252 |
|
| Circadian organization of lipid landscape is perturbed in type 2 diabetic patients | Cell reports medicine | | | 2023 | 283 | 166 |
|
| Stéatopathie non alcoolique (NAFLD) et diabète : le mauvais mariage | Revue médicale suisse | | | 2023 | 141 | 91 |
|
| Unnecessary thyroid surgery rate for suspicious nodule in the absence of molecular testing | European thyroid journal | | | 2023 | 223 | 814 |
|
| Traitement du diabète de type 2 : et si nous revenions à l’essentiel ? | Revue médicale suisse | | | 2023 | 103 | 92 |
|
| A multi–society Delphi consensus statement on new fatty liver disease nomenclature | Journal of hepatology | | | 2023 | 158 | 1,764 |
|
| The impact of transsphenoidal surgery on pituitary function in patients with non-functioning macroadenomas | Endocrine | | | 2023 | 156 | 431 |
|
| Neuropathie diabétique : mise au point | Revue médicale suisse | | | 2022 | 181 | 1,301 |
|
| Effectiveness of Therapeutic Patient Education Interventions in Obesity and Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials | Nutrients | | | 2022 | 198 | 340 |
|
| NAFLD: From Mechanisms to Therapeutic Approaches | Biomedicines | | | 2022 | 161 | 242 |
|
| Allergie à l’insuline : comment faire ? | Revue médicale suisse | | | 2022 | 154 | 763 |
|
| Non-alcoholic fatty liver disease in type 1 diabetes: prevalence and pathophysiology | Frontiers in endocrinology | | | 2022 | 164 | 419 |
|
| Diabète pancréatoprive | Revue médicale suisse | | | 2022 | 547 | 477 |
|
| Pheochromocytoma presented by Takotsubo, unmasked by accumulation of paroxetine, in a cytochrome poor metabolizer patient: A case report | Thérapie | | | 2022 | 377 | 1 |
|
| Interleukin-18 in metabolism: from mice physiology to human diseases | Frontiers in endocrinology | | | 2022 | 192 | 565 |
|
| Canakinumab in patients with COVID-19 and type 2 diabetes – a multicentre, randomised, double-blind, placebo-controlled trial | EClinicalMedicine | | | 2022 | 142 | 163 |
|
| Sex-specific modulation of circulating growth differentiation factor-15 in patients with type 2 diabetes and/or obesity | Endocrine connections | | | 2022 | 245 | 237 |
|
| (650) Efficacy of therapeutic patient education interventions in metabolic disorders: a systematic review and meta-analysis | 58th EASD Annual Meeting of the European Association for the Study of Diabetes | | | 2022 | 257 | 7 |
|
| Circulating 1,5-anhydroglucitol as a biomarker of ß-cell mass independent of a diabetes phenotype in human subjects | The Journal of clinical endocrinology and metabolism | | | 2022 | 430 | 2 |
|
| Moderate to Severe Soft Tissue Diabetic Foot Infections: A Randomized, Controlled, Pilot Trial of Post-debridement Antibiotic Treatment for 10 versus 20 days | Annals of surgery | | | 2022 | 270 | 484 |
|
| NADPH Oxidases Connecting Fatty Liver Disease, Insulin Resistance and Type 2 Diabetes: Current Knowledge and Therapeutic Outlook | Antioxidants | | | 2022 | 292 | 1,530 |
|
| Dernières recommandations européennes sur les dyslipidémies | Revue médicale suisse | | | 2022 | 403 | 1,870 |
|
| Hepatic non-parenchymal S100A9-TLR4-mTORC1 axis normalizes diabetic ketogenesis | Nature communications | | | 2022 | 393 | 142 |
|
| Diabète : la pandémie comme révélateur de nos succès/nos failles | Revue médicale suisse | | | 2022 | 62 | 59 |
|
| Diabétologie | Revue médicale suisse | | | 2022 | 101 | 80 |
|
| Hépatopathie et diabète de type 2 | Leading Opinions. Médecine Interne | | | 2022 | 130 | 0 |
|
| Tratamiento podológico del pie diabético | Encyclopédie médico-chirurgicale. Podología | | | 2022 | 135 | 0 |
|
| Systematic Review and Meta-Analysis of the Usefulness of Epicardial Fat Thickness as a Non-Invasive Marker of the Presence and Severity of Nonalcoholic Fatty Liver Disease | Biomedicines | | | 2022 | 165 | 169 |
|
| Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes | Cardiovascular diabetology | | | 2022 | 122 | 335 |
|
| Prise en charge podologique du pied diabétique | Encyclopédie médico-chirurgicale. Podologie | | | 2022 | 153 | 0 |
|
| Growth differentiation factor-15 prevents glucotoxicity and connexin-36 downregulation in pancreatic beta-cells | Molecular and cellular endocrinology | | | 2022 | 115 | 330 |
|
| Le diabète : une pandémie oubliée ? | Revue médicale suisse | | | 2021 | 135 | 321 |
|
| Inhibiteurs du SGLT2 : que des bénéfices? | Revue médicale suisse | | | 2021 | 391 | 508 |
|
| Is routine measurement of the serum C-reactive protein level helpful during antibiotic therapy for diabetic foot infection? | Diabetes, Obesity and Metabolism | | | 2021 | 200 | 0 |
|
| Diabète de type MODY : une entité souvent méconnue | Revue médicale suisse | | | 2021 | 195 | 396 |
|
| Ether lipids, sphingolipids and toxic 1-deoxyceramides as hallmarks for lean and obese type 2 diabetic patients | Acta Physiologica | | | 2021 | 408 | 3 |
|
| Diabétologie | Revue médicale suisse | | | 2021 | 213 | 2 |
|
| Pathophysiology of NASH in endocrine diseases | Endocrine Connections | | | 2021 | 244 | 354 |
|
| Hypothyroidism-Associated Dyslipidemia: Potential Molecular Mechanisms Leading to NAFLD | International journal of molecular sciences | | | 2021 | 167 | 415 |
|
| Diabétologie | Revue médicale suisse | | | 2020 | 253 | 2 |
|
| Diabète: et si on se mettait à la place du patient? | Revue médicale suisse | | | 2020 | 257 | 0 |
|
| Effectiveness and safety of insulin glargine 300 U/mL in insulin-naïve patients with type 2 diabetes after failure of oral therapy in a real-world setting | Diabetes, Obesity and Metabolism | | | 2020 | 499 | 382 |
|
| Thirteen-year trends in the prevalence of diabetes according to socioeconomic condition and cardiovascular risk factors in a swiss population | BMJ Open Diabetes Res Care | | | 2020 | 349 | 237 |
|
| Real-World Effectiveness of Insulin Glargine 300 Initiation in Switzerland | Diabetes, Metabolic Syndrome and Obesity | | | 2020 | 311 | 241 |
|
| La NASH: une complication moins connue mais importante du diabète | Revue médicale suisse | | | 2020 | 368 | 0 |
|
| The GLP-1R agonist liraglutide limits hepatic lipotoxicity and inflammatory response in mice fed a methionine-choline deficient diet | Translational Research | | | 2020 | 577 | 424 |
|
| Quelle place pour les inhibiteurs de la DPP-4 en 2020? | Revue médicale suisse | | | 2020 | 562 | 0 |
|
| Ulcère du pied chez un patient avec un diabète : quelle prise en charge médico-chirurgicale ? | Revue médicale suisse | | | 2020 | 355 | 1 |
|
| Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report | BMC Endocrine Disorders | | | 2020 | 219 | 171 |
|
| Diabète après transplantation rénale : mise au point | Revue médicale suisse | | | 2020 | 368 | 4 |
|
| Three versus six weeks of antibiotic therapy for diabetic foot osteomyelitis: A prospective, randomized, non-inferiority pilot trial | Clinical Infectious Diseases | | | 2020 | 354 | 1,344 |
|
| Insuffisance rénale chronique et nouveaux traitements antidiabétiques : tour d'horizon en 2019 | Revue médicale suisse | | | 2019 | 687 | 307 |
|
| Thirteen-year trends in the prevalence of diabetes in an urban region of Switzerland: a population-based study | Diabetic Medicine | | | 2019 | 272 | 0 |
|
| Salivary cortisol is not associated with incident insulin resistance or type 2 diabetes mellitus | Endocrine Connections | | | 2019 | 330 | 147 |
|
| Faut-il prescrire plus d'inhibiteurs SGLT-2 ? | Revue médicale suisse | | | 2019 | 316 | 182 |
|
| [News in diabetology 2018] | Revue médicale suisse | | | 2019 | 285 | 108 |
|
| Multi-technique comparison of atherogenic and MCD NASH models highlights changes in sphingolipid metabolism | Scientific Reports | | | 2019 | 484 | 144 |
|
| Nonalcoholic fatty liver disease burden | Swiss Medical Weekly | | | 2019 | 323 | 281 |
|
| Prise en charge de la dyslipidémie chez les patients avec un diabète de type 1 | Revue médicale suisse | | | 2018 | 531 | 135 |
|
| Diabétologie | Revue médicale suisse | | | 2018 | 426 | 99 |
|
| Observance thérapeutique et empilage médicamenteux | Revue médicale suisse | | | 2018 | 380 | 226 |
|
| Fibroblast Growth Factor 15/19 - From Basic Functions to Therapeutic Perspectives | Endocrine Reviews | | | 2018 | 510 | 350 |
|
| Transition optimale hôpital-domicile d'un patient diabétique de type 2 : quelques outils | Revue médicale suisse | | | 2018 | 578 | 236 |
|
| Consequences of the Adoption of the IADPSG versus Carpenter and Coustan Criteria to Diagnose Gestational Diabetes: A Before-After Comparison | Experimental and Clinical Endocrinology and Diabetes | | | 2018 | 525 | 2 |
|
| An Overview on Diabetic Foot Infections, including Issues Related to Associated Pain, Hyperglycemia and Limb Ischemia | Current Pharmaceutical Design | | | 2018 | 500 | 1 |
|
| Diabète prégestationnel : une entité de plus en plus fréquente | Revue médicale suisse | | | 2018 | 520 | 293 |
|
| Diabète de type 1, activité physique et nouvelles technologies | Revue médicale suisse | | | 2018 | 795 | 556 |
|
| β-Klotho deficiency protects against obesity through a crosstalk between liver, microbiota, and brown adipose tissue | JCI insight | | | 2017 | 596 | 302 |
|
| Utilité de la mesure en continu de la glycémie chez les patients diabétiques de type 2 | Revue médicale suisse | | | 2017 | 402 | 0 |
|
| Treatment challenges in type 1 diabetes after roux-en-Y gastric bypass | Swiss Medical Weekly | | | 2017 | 421 | 247 |
|
| AMPK activation caused by reduced liver lactate metabolism protects against hepatic steatosis in MCT1 haploinsufficient mice | Molecular Metabolism | | | 2017 | 426 | 0 |
|
| Diabète sucré secondaire à une endocrinopathie : quand y penser ? | Revue médicale suisse | | | 2017 | 560 | 1,207 |
|
| Diètes cétogènes : la solution miracle ? | Revue médicale suisse | | | 2017 | 1,358 | 926 |
|
| Effects of Ketogenic Diets on Cardiovascular Risk Factors: Evidence from Animal and Human Studies | Nutrients | | | 2017 | 480 | 0 |
|
| Translational Aspects of Diet and Non-Alcoholic Fatty Liver Disease | Nutrients | | | 2017 | 499 | 0 |
|
| Traitement du diabète: quand faire appel au diabétologue? | Revue médicale suisse | | | 2017 | 383 | 267 |
|
| Grip strength is not associated with incident type 2 diabetes mellitus in healthy adults: The CoLaus study | Diabetes Research and Clinical Practice | | | 2017 | 483 | 0 |
|
| Diabétologie | Revue médicale suisse | | | 2017 | 419 | 149 |
|
| GPR40 mediates potential positive effects of a saturated fatty acid enriched diet on bone | Molecular Nutrition and Food Research | | | 2017 | 575 | 482 |
|
| Effects of Antidiabetic Drugs on Gut Microbiota Composition | Genes | | | 2017 | 452 | 0 |
|
| Use of Dipeptidyl-Peptidase IV Inhibitors and Bullous Pemphigoid | Dermatology | | | 2017 | 436 | 0 |
|
| Optimization and testing of dried antibody tube: The EuroFlow LST and PIDOT tubes as examples | Journal of Immunological Methods | | | 2017 | 410 | 1 |
|
| Place des nouveaux antidiabétiques dans la population gériatrique | Revue médicale suisse | | | 2016 | 431 | 1 |
|
| Second-generation antisense oligonucleotides against β-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance | FASEB Journal | | | 2016 | 379 | 0 |
|
| Fasting glycaemia to simplify screening for gestational diabetes | BJOG: an International Journal of Obstetrics and Gynaecology | | | 2016 | 603 | 1 |
|
| Diabète gestationnel – quelles sont les approches non médicales ? | Revue médicale suisse | | | 2016 | 436 | 1 |
|
| Comment faire pour prévenir le diabète de type 2 en Suisse? | Revue médicale suisse | | | 2016 | 434 | 2 |
|
| Leptin as a Potential Regulator of FGF21 | Cellular physiology and biochemistry | | | 2016 | 640 | 293 |
|
| Preserving of Postnatal Leptin Signaling in Obesity-Resistant Lou/C Rats following a Perinatal High-Fat Diet | PloS one | | | 2016 | 530 | 219 |
|
| Sécurité cardiovasculaire des antidiabétiques | Revue médicale suisse | | | 2016 | 438 | 0 |
|
| Diabétologie | Revue médicale suisse | | | 2016 | 385 | 0 |
|
| Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection | Arteriosclerosis, Thrombosis, and Vascular Biology | | | 2016 | 636 | 1 |
|
| Low birth weight leads to obesity, diabetes and increased leptin levels in adults: the CoLaus study | Cardiovascular Diabetology | | | 2016 | 547 | 321 |
|
| Endocrine causes of nonalcoholic fatty liver disease | World Journal of Gastroenterology | | | 2015 | 496 | 0 |
|
| Free Fatty Acids Impair FGF21 Action in HepG2 Cells | Cellular physiology and biochemistry | | | 2015 | 572 | 985 |
|
| Metformine : nouvelles données pour une ancienne molécule | Revue médicale suisse | | | 2015 | 460 | 2 |
|
| Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21 | Journal of Endocrinology | | | 2015 | 833 | 538 |
|
| Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link? | Molecular and Cellular Endocrinology | | | 2015 | 550 | 2,090 |
|
| Classification du diabète : vers une hétérogénéité croissante | Revue médicale suisse | | | 2015 | 408 | 0 |
|
| Ketogenic Diet Impairs FGF21 Signaling and Promotes Differential Inflammatory Responses in the Liver and White Adipose Tissue | PloS one | | | 2015 | 638 | 587 |
|
| Le diabète en 2015 : en augmentation constante, mais avec une offre thérapeutique qui s'élargit | Revue médicale suisse | | | 2015 | 417 | 1 |
|
| Prise en charge des facteurs de risque des maladies cardiovasculaires : qu'est-ce qui a vraiment changé en 15 ans ? | Revue médicale suisse | | | 2015 | 438 | 1 |
|
| Edulcorants artificiels et diabète : faux amis ? | Revue médicale suisse | | | 2015 | 411 | 0 |
|
| ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content | Journal of Lipid Research | | | 2015 | 479 | 0 |
|
| Serum Vitamin D Concentrations Are Not Associated with Insulin Resistance in Swiss Adults | The Journal of nutrition | | | 2015 | 555 | 0 |
|
| Transition en diabétologie | Revue médicale suisse | | | 2015 | 573 | 1 |
|
| Diets and nonalcoholic fatty liver disease: The good and the bad | Clinical nutrition | | | 2014 | 690 | 1 |
|
| Capsule Commentary on Patrick et al., Trends in Insulin Initiation and Treatment Intensification among Patients with Type 2 Diabetes | Journal of general internal medicine | | | 2014 | 617 | 1 |
|
| Maladies hépatiques chroniques et diabète | Revue médicale suisse | | | 2014 | 503 | 0 |
|
| Traitement combiné d'insuline et d'analogue du GLP-1 : qu'en attendre ? | Revue médicale suisse | | | 2014 | 587 | 0 |
|
| Ostα-/- mice exhibit altered expression of intestinal lipid absorption genes, resistance to age-related weight gain, and modestly improved insulin sensitivity | American Journal of Physiology. Gastrointestinal and Liver Physiology | | | 2014 | 468 | 0 |
|
| Muscle-specific activation of Ca(2+)/calmodulin-dependent protein kinase IV increases whole-body insulin action in mice | Diabetologia | | | 2014 | 516 | 0 |
|
| Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice | Endocrinology | | | 2013 | 783 | 0 |
|
| CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance | Proceedings of the National Academy of Sciences | | | 2013 | 516 | 0 |
|
| Increased FGF21 plasma levels in humans with sepsis and SIRS | Endocrine connections | | | 2013 | 656 | 356 |
|
| Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside | Diabetes & metabolism | | | 2013 | 660 | 0 |
|
| Enhanced fasting glucose turnover in mice with disrupted action of TUG protein in skeletal muscle | Journal of Biological Chemistry | | | 2013 | 518 | 0 |
|
| Cellular mechanism by which estradiol protects female ovariectomized mice from high-fat diet-induced hepatic and muscle insulin resistance | Endocrinology | | | 2013 | 476 | 0 |
|
| Sport et diabète de type 1 | Revue médicale suisse | | | 2013 | 694 | 0 |
|
| Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance | Journal of Endocrinology | | | 2013 | 702 | 0 |
|
| Thyroid hormone receptor-α gene knockout mice are protected from diet-induced hepatic insulin resistance | Endocrinology | | | 2012 | 472 | 0 |
|
| Development of insulin resistance in mice lacking PGC-1α in adipose tissues | Proceedings of the National Academy of Sciences | | | 2012 | 429 | 0 |
|
| Dissociation of inositol-requiring enzyme (IRE1α)-mediated c-Jun N-terminal kinase activation from hepatic insulin resistance in conditional X-box-binding protein-1 (XBP1) knock-out mice | Journal of Biological Chemistry | | | 2012 | 448 | 0 |
|
| Sommeil et diabète | Revue médicale suisse | | | 2012 | 525 | 0 |
|
| Diabète et stéatose hépatique non alcoolique | Revue médicale suisse | | | 2012 | 646 | 0 |
|
| Weight and mortality in adults with diabetes | JAMA | | | 2012 | 608 | 0 |
|
| Insulin resistance is associated with elevated serum pigment epithelium-derived factor (PEDF) levels in morbidly obese patients | Acta Diabetologica | | | 2012 | 451 | 0 |
|
| Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice | Cell Metabolism | | | 2011 | 468 | 0 |
|
| Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance | Hepatology | | | 2011 | 456 | 1 |
|
| Pregnancy does not accelerate corticotroph tumor progression in Nelson's syndrome | Journal of Clinical Endocrinology and Metabolism | | | 2011 | 491 | 0 |
|
| SGLT2 deletion improves glucose homeostasis and preserves pancreatic beta-cell function | Diabetes | | | 2011 | 409 | 0 |
|
| Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2 | Proceedings of the National Academy of Sciences | | | 2011 | 519 | 0 |
|
| Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance | Cell Metabolism | | | 2010 | 479 | 0 |
|
| A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain | American Journal of Physiology. Endocrinology and Metabolism | | | 2010 | 455 | 0 |
|
| Effects of the peroxisome proliferator-activated receptor (PPAR)-gamma agonist pioglitazone on renal and hormonal responses to salt in diabetic and hypertensive individuals | Diabetologia | | | 2010 | 655 | 0 |
|
| Myeloperoxidase and paraoxonase-1 in type 2 diabetic patients | NMCD. Nutrition Metabolism and Cardiovascular Diseases | | | 2009 | 656 | 0 |
|
| Mucocutaneous papillomatous papules in Cowden's syndrome | Clinical and experimental dermatology | | | 2008 | 572 | 0 |
|
| Assessment of hepatic glucose metabolism by indirect calorimetry in combination with a non-invasive technique using naturally enriched 13C glucose in healthy children and adolescents | Hormone Research | | | 2004 | 439 | 0 |
|
| Metabolism of oral glucose in children born small for gestational age: evidence for an impaired whole body glucose oxidation | Metabolism | | | 2004 | 448 | 0 |
|
| Agenesis of human pancreas due to decreased half-life of insulin promoter factor 1 | The Journal of clinical endocrinology and metabolism | | | 2003 | 650 | 0 |
|
